Heterobicyclic thiophene compounds for the treatment of cancer

作者: John J. Gaudino , Allison L. Marlow , Allen A. Thomas , Meese Jason De , Hongqi Tian

DOI:

关键词:

摘要: Compounds of Formula I and pharmaceutically acceptable salts thereof, are useful for inhibiting receptor tyrosine kinases treating disorders mediated thereby. Methods using compounds in vitro, situ, vivo diagnosis, prevention or treatment such mammalian cells, associated pathological conditions disclosed.

参考文章(6)
Mingying He, Ru Zhou, Jihong Lou, Robert Steven Kania, Naphthalene carboxamides and their derivatives useful as new anti-angiogenic agents ,(2004)
Ljubomir Isakovic, Franck Raeppel, Stephane Raeppel, Arkadii Vaisburg, Amal Wahhab, Stephen William Claridge, Lijie Zhan, Naomy Bernstein, Frederic Gaudette, Marie-Claude Granger, Michael Mannion, Robert Deziel, Oscar Mario Saavedra, Nancy Zhou, Inhibitors of vegf receptor and hgf receptor signaling ,(2006)
Gui-Bai Liang, Songnian Lin, Shawn P. Walsh, Fiona Wai Yu Lau, Jiafang He, Min Ge, Lihu Yang, Weiguo Liu, Antidiabetic bicyclic compounds ,(2007)
Simon Paul Planken, Elizabeth Ann Lunney, Song Liu, Liming Huang, Substituted 2-amino-fused heterocyclic compounds ,(2007)
Michael Collins, Cynthia Louise Palmer, Jihong Lou, Robert Steven Kania, Ru Zhou, Judith Deal, Stephan Cripps, Mingying He, William Henry Romines, Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use ,(2003)